descriptive
Analysis v1
A drug called Rapamycin got approved by the US government in 1999 to help prevent organ rejection in transplant patients, especially when doctors want to avoid using another type of anti-rejection medicine.
Evidence from Studies
Supporting (0)
0
Community contributions welcome
No supporting evidence found
Contradicting (1)
0
Community contributions welcome
1
A treasure from a barren island: the discovery of rapamycin
Narrative Review
2022 OctThe study is about how rapamycin was discovered and how it works in the body, not about when the FDA approved it for use in transplant patients.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.